⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
globenewswire.com
ABBV
ABCL
AZN
BIIB
BMY
EXEL
GILD
GSK
INCY
LRCX
MRK
NVS
PFE
REGN
SNY
TMO
UCB
VRTX
Pharmaceutical Drug Delivery Market Forecasts Growth from $2.15T (2026) to $2.92T by 2031, Profiling J&J, Pfizer, Roche, BD & Novartis
globenewswire.com
JNJ
PFE
BDX
NVS
Lupus Nephritis Pipeline 2026: Targeted Therapies and Clinical Innovation Drive New Treatment and Market Opportunities Through the Forecast Period
globenewswire.com
NVS
Oncology Clinical Trials Market Set for Strong Growth Through 2035, Fueled by Precision Medicine, Immunotherapy and Decentralized Trial Innovation
globenewswire.com
AZN
MRK
NVS
LRCX
NVDA
GOOG
MSFT
AMGN
BMY
JNJ
PFE
LLY
ABBV
IQV
ICLR
LH
TMO
Bronstein, Gewirtz & Grossman, LLC Encourages Novartis AG (NVS) Stockholders to Inquire about Securities Investigation
accessnewswire.com
NVS
Hearing Loss Disease Treatment Market Advances as AI-Powered Hearing Aids Expand Patient Access Globally
globenewswire.com
PFE
NVS
GSK
Myotonic Dystrophy Market Expected to Grow Rapidly During the Forecast Period (2026-2036) as Pipeline Therapies Address Unmet Medical Needs | DelveInsight
prnewswire.com
AMPH
PEPG
VRTX
SRPT
NVS
Engitix appoints Sonia Quaratino, MD, PhD as EVP Chief Medical Officer as its ECM pipeline moves toward clinical development
globenewswire.com
NVS
MRK
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Novartis AG (NVS) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
NVS
Global Viral Vector Manufacturing Market -Projected to reach USD 12.84 Billion Market Value by 2036
globenewswire.com
TMO
LNZA
CRL
DHR
MRK
NVS